TY - JOUR
KW - Adult
KW - Aged
KW - Analgesics, Opioid/administration & dosage/adverse effects
KW - Chronic Pain/drug therapy
KW - Dose-Response Relationship, Drug
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Opioid-Related Disorders/epidemiology
KW - Practice Guidelines as Topic
KW - Prescription Drug Misuse/statistics & numerical data
KW - Prevalence
KW - Risk Reduction Behavior
KW - Washington
KW - Young Adult
KW - Chronic Pain
KW - Drug Abuse
KW - Opioids
KW - PRISM5
KW - practice change
KW - Prescription opioid use disorder
AU - M. Von Korff
AU - R. L. Walker
AU - K. Saunders
AU - S. M. Shortreed
AU - M. Thakral
AU - M. Parchman
AU - R. N. Hansen
AU - E. Ludman
AU - K. J. Sherman
AU - S. Dublin
A1 - 
AD - Kaiser Permanente Health Research Institute, Seattle, WA, USA. Electronic address: vonkorff.m@ghc.org.; Kaiser Permanente Health Research Institute, Seattle, WA, USA.; Kaiser Permanente Health Research Institute, Seattle, WA, USA.; Kaiser Permanente Health Research Institute, Seattle, WA, USA; Department of Biostatistics, University of Washington, USA.; Kaiser Permanente Health Research Institute, Seattle, WA, USA.; Kaiser Permanente Health Research Institute, Seattle, WA, USA.; School of Pharmacy, University of Washington, Seattle, WA, USA.; Kaiser Permanente Health Research Institute, Seattle, WA, USA.; Kaiser Permanente Health Research Institute, Seattle, WA, USA; Department of Epidemiology, University of Washington, USA.; Kaiser Permanente Health Research Institute, Seattle, WA, USA; Department of Epidemiology, University of Washington, USA.
BT - The International journal on drug policy
C5 - Opioids & Substance Use
CY - Netherlands
JF - The International journal on drug policy
M1 - Journal Article
PB - Elsevier B.V
PP - Netherlands
PY - 2017
SN - 1873-4758; 0955-3959
SP - 90
EP - 98
EP - 
T1 - Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives
T2 - The International journal on drug policy
TI - Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives
U1 - Opioids & Substance Use
U2 - 28666143
VL - 46
VO - 1873-4758; 0955-3959
Y1 - 2017
Y2 - Aug
ER -